Many venture capitalists took to Twitter on Monday night, decrying news that the U.S. Supreme Court appears poised to overturn Roe v. Wade. Soon they'll have a chance to put their money where their mouths are.
Driving the news: Hey Jane, a U.S. telemedicine startup specializing in abortion pills, plans to seek a Series A round later this spring.
